LB Pharmaceuticals (LBRX) announced the appointments of Ellen Rose as Senior Vice President, Corporate Affairs and Lindsay Beaupre as Senior Vice President, People and Culture. Prior to joining LB Pharmaceuticals, Ms. Rose served as Senior Vice President, Communications and Investor Relations at Lyell Immunopharma. Most recently Ms. Beaupre was the Chief Administrative Officer at Lyndra Therapeutics.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LBRX:
- These 3 Biotech Stocks Can Triple from Current Levels, Say Five-Star Analysts – 12/19/2025
- LB Pharmaceuticals management to meet with Piper Sandler
- LB Pharmaceuticals price target raised to $35 from $27 at Stifel
- LB Pharmaceuticals added to Russell 2000, Russell 3000 indices
- LB Pharmaceuticals Expands Lease at One Penn Plaza